144 related articles for article (PubMed ID: 16899230)
1. Cardiovascular effects of mixed amphetamine salts extended release in the treatment of school-aged children with attention-deficit/hyperactivity disorder.
Donner R; Michaels MA; Ambrosini PJ
Biol Psychiatry; 2007 Mar; 61(5):706-12. PubMed ID: 16899230
[TBL] [Abstract][Full Text] [Related]
2. Short- and long-term cardiovascular effects of mixed amphetamine salts extended release in children.
Findling RL; Biederman J; Wilens TE; Spencer TJ; McGough JJ; Lopez FA; Tulloch SJ;
J Pediatr; 2005 Sep; 147(3):348-54. PubMed ID: 16182674
[TBL] [Abstract][Full Text] [Related]
3. A community assessment, open-label study of the safety, tolerability, and effectiveness of mixed amphetamine salts extended release in school-age children with ADHD.
Ambrosini PJ; Sallee FR; Lopez FA; Shi L; Michaels MA;
Curr Med Res Opin; 2006 Feb; 22(2):427-40. PubMed ID: 16466615
[TBL] [Abstract][Full Text] [Related]
4. A post hoc subgroup analysis of an 18-day randomized controlled trial comparing the tolerability and efficacy of mixed amphetamine salts extended release and atomoxetine in school-age girls with attention-deficit/hyperactivity disorder.
Biederman J; Wigal SB; Spencer TJ; McGough JJ; Mays DA
Clin Ther; 2006 Feb; 28(2):280-93. PubMed ID: 16678649
[TBL] [Abstract][Full Text] [Related]
5. Efficacy and safety of mixed amphetamine salts extended release (adderall XR) in the management of oppositional defiant disorder with or without comorbid attention-deficit/hyperactivity disorder in school-aged children and adolescents: A 4-week, multicenter, randomized, double-blind, parallel-group, placebo-controlled, forced-dose-escalation study.
Spencer TJ; Abikoff HB; Connor DF; Biederman J; Pliszka SR; Boellner S; Read SC; Pratt R
Clin Ther; 2006 Mar; 28(3):402-18. PubMed ID: 16750455
[TBL] [Abstract][Full Text] [Related]
6. Transition from methylphenidate or amphetamine to atomoxetine in children and adolescents with attention-deficit/hyperactivity disorder--a preliminary tolerability and efficacy study.
Quintana H; Cherlin EA; Duesenberg DA; Bangs ME; Ramsey JL; Feldman PD; Allen AJ; Kelsey DK
Clin Ther; 2007 Jun; 29(6):1168-77. PubMed ID: 17692731
[TBL] [Abstract][Full Text] [Related]
7. Phase I, double-blind, randomized, placebo-controlled, dose-escalation study of the effects on blood pressure of abrupt cessation versus taper down of guanfacine extended-release tablets in adults aged 19 to 24 years.
Kisicki JC; Fiske K; Lyne A
Clin Ther; 2007 Sep; 29(9):1967-79. PubMed ID: 18035196
[TBL] [Abstract][Full Text] [Related]
8. Long-term tolerability and effectiveness of once-daily mixed amphetamine salts (Adderall XR) in children with ADHD.
McGough JJ; Biederman J; Wigal SB; Lopez FA; McCracken JT; Spencer T; Zhang Y; Tulloch SJ
J Am Acad Child Adolesc Psychiatry; 2005 Jun; 44(6):530-8. PubMed ID: 15908835
[TBL] [Abstract][Full Text] [Related]
9. Cardiovascular effects of longer-term, high-dose OROS methylphenidate in adolescents with attention deficit hyperactivity disorder.
Hammerness P; Wilens T; Mick E; Spencer T; Doyle R; McCreary M; Becker J; Biederman J
J Pediatr; 2009 Jul; 155(1):84-9, 89.e1. PubMed ID: 19394037
[TBL] [Abstract][Full Text] [Related]
10. Forecasting three-month outcomes in a laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children With ADHD.
Faraone SV; Wigal SB; Hodgkins P
J Atten Disord; 2007 Jul; 11(1):74-82. PubMed ID: 17606774
[TBL] [Abstract][Full Text] [Related]
11. A laboratory school comparison of mixed amphetamine salts extended release (Adderall XR) and atomoxetine (Strattera) in school-aged children with attention deficit/hyperactivity disorder.
Wigal SB; McGough JJ; McCracken JT; Biederman J; Spencer TJ; Posner KL; Wigal TL; Kollins SH; Clark TM; Mays DA; Zhang Y; Tulloch SJ
J Atten Disord; 2005 Aug; 9(1):275-89. PubMed ID: 16371674
[TBL] [Abstract][Full Text] [Related]
12. Effects of once-daily osmotic-release methylphenidate on blood pressure and heart rate in children with attention-deficit/hyperactivity disorder: results from a one-year follow-up study.
Wilens TE; Biederman J; Lerner M;
J Clin Psychopharmacol; 2004 Feb; 24(1):36-41. PubMed ID: 14709945
[TBL] [Abstract][Full Text] [Related]
13. Relative benefits of stimulant therapy with OROS methylphenidate versus mixed amphetamine salts extended release in improving the driving performance of adolescent drivers with attention-deficit/hyperactivity disorder.
Cox DJ; Merkel RL; Moore M; Thorndike F; Muller C; Kovatchev B
Pediatrics; 2006 Sep; 118(3):e704-10. PubMed ID: 16950962
[TBL] [Abstract][Full Text] [Related]
14. A randomized, double-blind, placebo-controlled study of guanfacine extended release in children and adolescents with attention-deficit/hyperactivity disorder.
Biederman J; Melmed RD; Patel A; McBurnett K; Konow J; Lyne A; Scherer N;
Pediatrics; 2008 Jan; 121(1):e73-84. PubMed ID: 18166547
[TBL] [Abstract][Full Text] [Related]
15. Single- and multiple-dose pharmacokinetics of an oral mixed amphetamine salts extended-release formulation in adults.
Clausen SB; Read SC; Tulloch SJ
CNS Spectr; 2005 Dec; 10(12 Suppl 20):6-15. PubMed ID: 16344836
[TBL] [Abstract][Full Text] [Related]
16. Onset of efficacy of long-acting psychostimulants in pediatric attention-deficit/hyperactivity disorder.
Brams M; Mao AR; Doyle RL
Postgrad Med; 2008 Sep; 120(3):69-88. PubMed ID: 18824827
[TBL] [Abstract][Full Text] [Related]
17. Evolution of the treatment of attention-deficit/hyperactivity disorder in children: a review.
Findling RL
Clin Ther; 2008 May; 30(5):942-57. PubMed ID: 18555941
[TBL] [Abstract][Full Text] [Related]
18. Modafinil in children and adolescents with attention-deficit/hyperactivity disorder: a preliminary 8-week, open-label study.
Boellner SW; Earl CQ; Arora S
Curr Med Res Opin; 2006 Dec; 22(12):2457-65. PubMed ID: 17257460
[TBL] [Abstract][Full Text] [Related]
19. An open-label study of the tolerability of mixed amphetamine salts in adults with attention-deficit/hyperactivity disorder and treated primary essential hypertension.
Wilens TE; Zusman RM; Hammerness PG; Podolski A; Whitley J; Spencer TJ; Gignac M; Biederman J
J Clin Psychiatry; 2006 May; 67(5):696-702. PubMed ID: 16841618
[TBL] [Abstract][Full Text] [Related]
20. Long-term cardiovascular effects of mixed amphetamine salts extended release in adults with ADHD.
Weisler RH; Biederman J; Spencer TJ; Wilens TE
CNS Spectr; 2005 Dec; 10(12 Suppl 20):35-43. PubMed ID: 16344839
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
